GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer
Status:
Recruiting
Trial end date:
2024-02-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the prophylactic effects of Ganglioside-Monosialic
Acid in post-chemotherapy cognitive impairment in patients with early operable breast cancer.